SCHEMBL6653449

SCHEMBL6653449

CCOC(=O)CNc1ccccc1Nc1ccc(C(=O)c2ccccc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 4/20 0.51
MAPK12 P53778 4/20 0.51
MAPK11 Q15759 4/20 0.51
MAPK14 Q16539 4/20 0.51
RAB9A P51151 3/20 0.46
ALDH1A1 P00352 3/20 0.46
HPGD P15428 2/20 0.46
SMN1; SMN2 Q16637 4/20 0.45
NPC1 O15118 1/20 0.45
GAA P10253 1/20 0.45
LMNA P02545 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.44
KDM4E B2RXH2 1/20 0.44
HTT P42858 1/20 0.44
POLB P06746 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
ELANE P08246 1/20 0.43
PPID Q08752 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6653381 0.82 MAPK13 (0.60) MAPK13MAPK12MAPK11MAPK14RAB9A
SCHEMBL6655128 0.82 MAPK13 (0.57) MAPK13MAPK12MAPK11MAPK14RAB9A
SCHEMBL6607746 0.81 ALDH1A1 (0.50) RAB9AALDH1A1HPGDSMN1; SMN2NPC1
SCHEMBL6657101 0.77 MAPK13 (0.55) MAPK13MAPK12MAPK11MAPK14RAB9A
SCHEMBL11456258 0.77 L3MBTL1 (0.56) RAB9AALDH1A1SMN1; SMN2GAALMNA
SCHEMBL6656369 0.74 MAPK13 (0.66) MAPK13MAPK12MAPK11MAPK14RAB9A
SCHEMBL5786263 0.74 GAA (0.54) RAB9AALDH1A1SMN1; SMN2NPC1GAA
SCHEMBL6813175 0.74 MAPK14 (0.74) MAPK13MAPK12MAPK11MAPK14KDM4E
SCHEMBL62893 0.74 POLB (0.60) RAB9AALDH1A1HPGDSMN1; SMN2GAA
SCHEMBL31518574 0.74 KDM4E (0.58) RAB9AALDH1A1HPGDSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0966424-B1 AMINOBENZOPHENONES AS INHIBITORS OF INTERLEUKIN AND TNF LEO PHARMA AS (DK) 2004-06-23 EP claimed
EP-0966424-B1 AMINOBENZOPHENONES AS INHIBITORS OF INTERLEUKIN AND TNF LEO PHARMA AS (DK) 2004-06-23 EP disclosed
US-6313174-B1 FOR THERAPY AND PROPHYLAXIS OF ASTHMA, ALLERGY, RHEUMATOID ARTHRITIS, SPONDYLOARTHRITIS, GOUT, ATHEROSCLEROSIS, CHRONIC INFLAMMATORY BOWEL DISEASE, PROLIFERATIVE AND INFLAMMATORY SKIN DISORDERS Leo Pharmaceutical Products Ltd.A/S/ (Løvens kemiske Fabrik Produktionsaktieselskab) (DK) 2001-11-06 US disclosed
EP-0966424-A1 AMINOBENZOPHENONES AS INHIBITORS OF INTERLEUKIN AND TNF LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) 1999-12-29 EP disclosed
WO-1998032730-A1 AMINOBENZOPHENONES AS INHIBITORS OF INTERLEUKIN AND TNF Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) (DK) 1998-07-30 WO disclosed